Kindstar Globalgene Technology (HKSE:09960) Moat Score: 0/10 (As of Aug. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:09960 Kindstar Globalgene Technology Inc HKSE:09960
69 GF Score
Price HK$1.00
GF Value HK$1.06
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Kindstar Globalgene Technology Moat Score?

Kindstar Globalgene Technology has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Kindstar Globalgene Technology has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Kindstar Globalgene Technology might have No Moat - No discernible moat.

Kindstar Globalgene Technology  (HKSE:09960) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Kindstar Globalgene Technology Moat Score Related Terms

HKSE:09960
69GF Score
Kindstar Globalgene Technology Inc HKSE:09960
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Kindstar Globalgene Technology (HKSE:09960) Overvalued in 2026?

Based on GuruFocus' analysis, Kindstar Globalgene Technology stock appears to be undervalued. The current stock price of HK$1.00 is trading 5.7% below its estimated GF Value™ of HK$1.06. GuruFocus considers Kindstar Globalgene Technology to be Fairly Valued.

Key valuation signals for HKSE:09960:

  • Moat Score: 0
  • GF Value™: HK$1.06 vs. price of HK$1.00 (5.7% below fair value)
  • GF Score™: 69/100 with 6 warning signs

No single metric tells the full story. See the HKSE:09960 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kindstar Globalgene Technology Business Description

Address Biolake D2-1, 666 Gaoxin Road, East Lake High Tech Zone, Hubei Province, Wuhan, CHN
Kindstar Globalgene Technology Inc is engaged in the provision of clinical testing services in China. It operates in nine segments: Hematology testing segment includes testing services related to blood diseases; Genetic diseases and rare diseases segment includes testing services for rare diseases; Infectious diseases segment includes testing services from the infection department; Oncology segment includes testing related to oncology diseases; Neurology segment includes testing services related to neurological diseases undertaken by the Group; Maternity-related diseases segment includes testing services related to maternity; Routine testing segment conducts routine tests for the doctors daily diagnoses; CROs & R&D project segment includes research & develop services; & others segment.
69GF Score

Get the complete analysis for HKSE:09960

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$1.00
Price
HK$1.06
GF Value